DAWN Q4 2025 Earnings Miss on EPS as PreRevenue Biotech Invests in Pipeline Dyne Therapeutics Q1 2026 Earnings EPS Beat Amid Ongoing Clinical Focus Cousins Properties CUZ Q1 2026 Earnings EPS Beats Expectations Amid Stable Office Market Ford Q1 2026 Earnings Massive EPS Surprise of 245 Drives Strong Rally PEBK Q4 2025 Earnings Strong EPS Performance Amid Quiet Trading SPRB Q1 2026 Earnings Narrowerthanexpected loss as pipeline progress continues